Search research articles
Contact Us
Filters
Showing results (191-200 of 208) with videos related to
Page
of 21
Sort By:
JAMA Oncology
|
February 15, 2017
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033
Michael C Heinrich, Cathryn Rankin, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2003
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
Michael C Heinrich, Christopher L Corless, George D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Michael C Heinrich, Christopher L Corless, George D Demetri, et al.
Archives of Pathology & Laboratory Medicine
|
August 4, 2006
Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experience
George J Netto, David L Watkins, James W Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response
Mayra Yebra, Shruti Bhargava, Avi Kumar, et al.
The Journal of Pathology
|
November 6, 2009
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
Subbaya Subramanian, Venugopal Thayanithy, Robert B West, et al.
The Journal of Molecular Diagnostics : JMD
|
December 15, 2019
Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Deepika Sirohi, Robert L Schmidt, Dara L Aisner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
Richard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial
Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Journal of Translational Medicine
|
December 16, 2016
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors
Eileen Shi, Juliann Chmielecki, Chih-Min Tang, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 208) with videos related to
Sort By:
Page
of 21
JAMA Oncology
|
February 15, 2017
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033
Michael C Heinrich, Cathryn Rankin, Charles D Blanke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 4, 2003
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
Michael C Heinrich, Christopher L Corless, George D Demetri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
Michael C Heinrich, Christopher L Corless, George D Demetri, et al.
Archives of Pathology & Laboratory Medicine
|
August 4, 2006
Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experience
George J Netto, David L Watkins, James W Williams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2021
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response
Mayra Yebra, Shruti Bhargava, Avi Kumar, et al.
The Journal of Pathology
|
November 6, 2009
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours
Subbaya Subramanian, Venugopal Thayanithy, Robert B West, et al.
The Journal of Molecular Diagnostics : JMD
|
December 15, 2019
Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer
Deepika Sirohi, Robert L Schmidt, Dara L Aisner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition
Richard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial
Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Journal of Translational Medicine
|
December 16, 2016
FGFR1 and NTRK3 actionable alterations in "Wild-Type" gastrointestinal stromal tumors
Eileen Shi, Juliann Chmielecki, Chih-Min Tang, et al.
Page
of 21